Medicines for Malaria Venture (MMV)
@mmv.org
A leading global health partnership working to reduce the burden of malaria. We discover, develop and deliver new antimalarial medicines.
MMV is at #ASTMH25!
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
November 10, 2025 at 5:13 PM
MMV is at #ASTMH25!
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
Heading to #ASTMH2025 in Toronto? 🇨🇦
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
November 7, 2025 at 10:40 AM
Heading to #ASTMH2025 in Toronto? 🇨🇦
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
MMV staff are celebrating #MalariaDayInTheAmericas by joining the Brazilian #MedTrop25 Conference in Belém this week!
November 6, 2025 at 8:06 PM
MMV staff are celebrating #MalariaDayInTheAmericas by joining the Brazilian #MedTrop25 Conference in Belém this week!
Symposium: MMV & partners at #ASTMH2025
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
November 3, 2025 at 6:08 PM
Symposium: MMV & partners at #ASTMH2025
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
MMV & Chiang Mai University have launched a qualitative study in Thailand on paediatric formulations of primaquine and tafenoquine for P. vivax #malaria relapse prevention, exploring perceptions around their use with G6PD testing.
October 30, 2025 at 11:12 AM
MMV & Chiang Mai University have launched a qualitative study in Thailand on paediatric formulations of primaquine and tafenoquine for P. vivax #malaria relapse prevention, exploring perceptions around their use with G6PD testing.
Malaria can become deadly within hours. Through SEMA ReACT, MMV & partners are studying rectal artesunate use in remote Zambia & DRC to improve severe #malaria care. Join us at #ASTMH2025 (11 Nov) for a symposium sharing interim results & insights 👉 bit.ly/46Z7ADQ
October 29, 2025 at 3:37 PM
Malaria can become deadly within hours. Through SEMA ReACT, MMV & partners are studying rectal artesunate use in remote Zambia & DRC to improve severe #malaria care. Join us at #ASTMH2025 (11 Nov) for a symposium sharing interim results & insights 👉 bit.ly/46Z7ADQ
Diversifying the use of #malaria meds through the deployment of MFT can keep us one step ahead of resistance. MMV & partners recently conducted a feasibility study in Kenya demonstrating that an MFT approach is feasible, with adequate resources 👉 bit.ly/3IVeQYh
October 29, 2025 at 1:54 PM
Diversifying the use of #malaria meds through the deployment of MFT can keep us one step ahead of resistance. MMV & partners recently conducted a feasibility study in Kenya demonstrating that an MFT approach is feasible, with adequate resources 👉 bit.ly/3IVeQYh
Are you subscribed to MMV’s monthly newsletter?
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
October 28, 2025 at 8:36 AM
Are you subscribed to MMV’s monthly newsletter?
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
“Innovation can’t wait; we need to act now,” says MMV CEO Martin Fitchet, in an opinion piece on the urgent need to stop #malaria drug resistance in its tracks. Read it in @devex.com
👉 bit.ly/42UQ8xU
👉 bit.ly/42UQ8xU
October 23, 2025 at 8:00 AM
“Innovation can’t wait; we need to act now,” says MMV CEO Martin Fitchet, in an opinion piece on the urgent need to stop #malaria drug resistance in its tracks. Read it in @devex.com
👉 bit.ly/42UQ8xU
👉 bit.ly/42UQ8xU
A #malaria resurgence would cost lives and crush economies.
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
October 21, 2025 at 10:27 AM
A #malaria resurgence would cost lives and crush economies.
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
Growing research infrastructure, stronger regulatory frameworks & new opportunities for collaboration are shifting Africa’s clinical trial landscape. 👉 See how harnessing Africa’s untapped clinical trial potential can benefit patients & business: bit.ly/4qema1Z
October 20, 2025 at 1:35 PM
Growing research infrastructure, stronger regulatory frameworks & new opportunities for collaboration are shifting Africa’s clinical trial landscape. 👉 See how harnessing Africa’s untapped clinical trial potential can benefit patients & business: bit.ly/4qema1Z
One country’s victory over #malaria can light the way for others. Suriname's path to elimination was forged by combining community engagement, rapid testing & effective treatment – an approach that can inspire strategies in other countries 👉 bit.ly/4q4jK5R
October 17, 2025 at 10:23 AM
One country’s victory over #malaria can light the way for others. Suriname's path to elimination was forged by combining community engagement, rapid testing & effective treatment – an approach that can inspire strategies in other countries 👉 bit.ly/4q4jK5R
Are we focusing on the most critical levers to end #malaria? Join MMV & @gatesfoundation.bsky.social at #ASTMH2025 to explore how breakthrough tools, smart strategies and endemic country leadership can help end malaria in our lifetime.
📅 Nov 12, 7:00am bit.ly/4356K60
📅 Nov 12, 7:00am bit.ly/4356K60
October 15, 2025 at 10:12 AM
Are we focusing on the most critical levers to end #malaria? Join MMV & @gatesfoundation.bsky.social at #ASTMH2025 to explore how breakthrough tools, smart strategies and endemic country leadership can help end malaria in our lifetime.
📅 Nov 12, 7:00am bit.ly/4356K60
📅 Nov 12, 7:00am bit.ly/4356K60
#DayOfTheGirl is a reminder that #malaria elimination is only possible if we do what it takes to protect all groups of patients – and build a world where no one’s future can be compromised by a disease that is entirely preventable and treatable. 🌍✨
October 11, 2025 at 10:17 AM
#DayOfTheGirl is a reminder that #malaria elimination is only possible if we do what it takes to protect all groups of patients – and build a world where no one’s future can be compromised by a disease that is entirely preventable and treatable. 🌍✨
Yesterday, MMV and Africa CDC invited partners to a workshop in Accra to exchange insights and brainstorm ways to strengthen regional supply chains for #malaria medicines in Africa.
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
October 7, 2025 at 1:44 PM
Yesterday, MMV and Africa CDC invited partners to a workshop in Accra to exchange insights and brainstorm ways to strengthen regional supply chains for #malaria medicines in Africa.
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
Meet the organization built on the values it takes to achieve a malaria-free future – collaboration, innovation, openness and equity.
Together, we can end #malaria – will you join us?
Together, we can end #malaria – will you join us?
September 30, 2025 at 9:39 AM
Meet the organization built on the values it takes to achieve a malaria-free future – collaboration, innovation, openness and equity.
Together, we can end #malaria – will you join us?
Together, we can end #malaria – will you join us?
SMC, vector control & vaccines are a powerful trio against #malaria.
A new PLOS Health review shows SMC cuts illness & deaths in kids <5 in Africa’s Sahel — but scaling it means tackling logistics, adherence & access in remote areas.
👉bit.ly/46wcCGB
A new PLOS Health review shows SMC cuts illness & deaths in kids <5 in Africa’s Sahel — but scaling it means tackling logistics, adherence & access in remote areas.
👉bit.ly/46wcCGB
September 26, 2025 at 11:14 AM
SMC, vector control & vaccines are a powerful trio against #malaria.
A new PLOS Health review shows SMC cuts illness & deaths in kids <5 in Africa’s Sahel — but scaling it means tackling logistics, adherence & access in remote areas.
👉bit.ly/46wcCGB
A new PLOS Health review shows SMC cuts illness & deaths in kids <5 in Africa’s Sahel — but scaling it means tackling logistics, adherence & access in remote areas.
👉bit.ly/46wcCGB
Today, MMV and @deepmirror.bsky.social convened 40+ scientists in Geneva to co-create the dd4gh platform. Together, we’re using AI/ML to accelerate #malaria drug discovery while building a more inclusive global research community. Next stop: Accra.
👉 Read more: bit.ly/46xigrJ
👉 Read more: bit.ly/46xigrJ
September 24, 2025 at 12:58 PM
Today, MMV and @deepmirror.bsky.social convened 40+ scientists in Geneva to co-create the dd4gh platform. Together, we’re using AI/ML to accelerate #malaria drug discovery while building a more inclusive global research community. Next stop: Accra.
👉 Read more: bit.ly/46xigrJ
👉 Read more: bit.ly/46xigrJ
A single dose, a stronger #malaria elimination strategy.
👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj
👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj
September 23, 2025 at 8:38 AM
A single dose, a stronger #malaria elimination strategy.
👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj
👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj
In @telegraphnews.bsky.social, Dr Ibrahima Socé Fall argues that tackling #malaria, #dengue & #TB is key to saving lives today and preparing for future outbreaks of pandemic potential. 👉 bit.ly/3I4hcU0
September 16, 2025 at 8:57 AM
In @telegraphnews.bsky.social, Dr Ibrahima Socé Fall argues that tackling #malaria, #dengue & #TB is key to saving lives today and preparing for future outbreaks of pandemic potential. 👉 bit.ly/3I4hcU0
📢 The Big Push Against Malaria is accelerating global progress towards eradication. On the sidelines, the SMC Alliance — including MMV — is reaffirming the crucial role of seasonal #malaria chemoprevention in protecting children during peak seasons 👉 bit.ly/4ngUhUr
September 11, 2025 at 11:05 AM
📢 The Big Push Against Malaria is accelerating global progress towards eradication. On the sidelines, the SMC Alliance — including MMV — is reaffirming the crucial role of seasonal #malaria chemoprevention in protecting children during peak seasons 👉 bit.ly/4ngUhUr
Partial resistance to artemisinin threatens #malaria treatments (ACTs) and risks undoing decades of progress. A new @thelancetinfdis.bsky.social study shows how diversifying ACT use in endemic countries could protect efficacy & buy time for next-gen drugs. 👉 bit.ly/41yFRH1
September 9, 2025 at 7:48 AM
Partial resistance to artemisinin threatens #malaria treatments (ACTs) and risks undoing decades of progress. A new @thelancetinfdis.bsky.social study shows how diversifying ACT use in endemic countries could protect efficacy & buy time for next-gen drugs. 👉 bit.ly/41yFRH1
This Wednesday, @path.org will host a webinar on expanding the impact of #malaria chemoprevention. Join to learn about implementation experiences & how to deliver these prevention tools more widely & equitably. Register here 👉 bit.ly/3UZRDXa
September 8, 2025 at 3:08 PM
This Wednesday, @path.org will host a webinar on expanding the impact of #malaria chemoprevention. Join to learn about implementation experiences & how to deliver these prevention tools more widely & equitably. Register here 👉 bit.ly/3UZRDXa
Africa is facing a perfect storm against #malaria, including drug resistance, critical funding gaps & climate change.
At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv
At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv
September 5, 2025 at 10:20 AM
Africa is facing a perfect storm against #malaria, including drug resistance, critical funding gaps & climate change.
At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv
At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv